We are live on ! Find out more
IMNM icon

Immunome
IMNM

57 hedge funds and large institutions have $230M invested in Immunome in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,071% more capital invested

Capital invested by funds: $19.7M → $230M (+$210M)

440% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 5

430% more call options, than puts

Call options by funds: $806K | Put options by funds: $152K

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

63% more funds holding

Funds holding: 35 → 57 (+22)

30.95% more ownership

Funds ownership: 19.37% → 50.32% (+31%)

Holders
57
Holders Change
+22
Holders Change %
+62.86%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
27
Increased
16
Reduced
6
Closed
5
Calls
$806K
Puts
$152K
Net Calls
+$654K
Net Calls Change
+$484K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.5M
2
EC
EcoR1 Capital
California
+$32.3M
3
RG
Redmile Group
California
+$32.3M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$11.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
AGM
Alpine Global Management
New York
-$1.44M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$693K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$255K
4
SSA
Schonfeld Strategic Advisors
New York
-$152K
5
Simplex Trading
Simplex Trading
Illinois
-$102K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$385K +$57.6K +6,927 +24%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$373K +$80.6K +9,698 +39%
ECM
28
ExodusPoint Capital Management
New York
$355K +$276K +33,142 New
State Street
29
State Street
Massachusetts
$327K +$8.31K +1,000 +3%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$315K +$7.71K +928 +3%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$307K +$238K +28,649 New
6CM
32
683 Capital Management
New York
$290K +$226K +27,149 New
MFG
33
Magnus Financial Group
New York
$276K – – –
BIM
34
Baldwin Investment Management
Pennsylvania
$272K – – –
Bank of America
35
Bank of America
North Carolina
$269K +$208K +25,071 +46,428%
Morgan Stanley
36
Morgan Stanley
New York
$260K +$101K +12,155 +100%
Man Group
37
Man Group
United Kingdom
$251K +$195K +23,490 New
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$202K -$255K -30,707 -62%
JP Morgan Chase
39
JP Morgan Chase
New York
$196K +$152K +18,302 New
SIAP
40
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$182K +$141K +16,965 New
HighTower Advisors
41
HighTower Advisors
Illinois
$180K -$16.6K -2,000 -11%
JF
42
Jump Financial
Illinois
$172K +$134K +16,100 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$170K +$132K +15,844 New
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$150K -$11.5K -1,379 -9%
Wealth Enhancement Advisory Services
45
Wealth Enhancement Advisory Services
Minnesota
$139K +$108K +13,000 New
MFS
46
Mirabella Financial Services
United Kingdom
$131K +$101K +12,200 New
CSS
47
Cubist Systematic Strategies
Connecticut
$110K +$82.7K +9,947 +3,327%
Lazard Asset Management
48
Lazard Asset Management
New York
$82K +$64K +7,700 New
Simplex Trading
49
Simplex Trading
Illinois
$29K -$102K -12,222 -82%
Citadel Advisors
50
Citadel Advisors
Florida
$28.1K -$40.4K -4,863 -65%
1
2
3

IMNM Hedge Fund Activity: Q4 2023 in Review

57 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q4 2023, worth a combined $230M — up 1,071% from $19.7M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IMNM positions and 5 closed out — a net gain of 22 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $32.5M. The largest seller was Alpine Global Management, cutting an estimated $1.44M.

  • 57 institutional investors held Immunome (IMNM) as of Q4 2023, up from 35 in Q3 2023.
  • Funds reported $230M of Immunome stock for Q4 2023, up 1,071% quarter-over-quarter.
  • 27 funds opened new Immunome positions in Q4 2023 and 5 closed out, a net change of +22 holders.
  • The largest Immunome buyer in Q4 2023 was Fidelity Investments, an estimated $32.5M added.
  • The largest Immunome seller in Q4 2023 was Alpine Global Management, an estimated $1.44M sold.

Based on aggregated 13F filings for Q4 2023.